Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Times Interest Earned (2016 - 2025)

Northwest Biotherapeutics' Times Interest Earned history spans 16 years, with the latest figure at $12.56 for Q4 2025.

  • Quarterly results put Times Interest Earned at $12.56 for Q4 2025, up 2.72% from a year ago — trailing twelve months through Dec 2025 was -$1.52 (up 33.07% YoY), and the annual figure for FY2025 was -$1.52, up 33.07%.
  • Times Interest Earned for Q4 2025 was $12.56 at Northwest Biotherapeutics, up from -$5.46 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $12.56 in Q4 2025 to a low of -$15.37 in Q2 2021.
  • The 5-year median for Times Interest Earned is -$10.35 (2022), against an average of -$8.09.
  • The sharpest move saw Times Interest Earned plummeted 116.05% in 2021, then surged 200.27% in 2024.
  • Year by year, Times Interest Earned stood at -$9.26 in 2021, then tumbled by 60.79% to -$14.89 in 2022, then grew by 18.11% to -$12.19 in 2023, then surged by 200.27% to $12.23 in 2024, then grew by 2.72% to $12.56 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at $12.56, -$5.46, and -$8.09 for Q4 2025, Q3 2025, and Q2 2025 respectively.